64 results
Page 2 of 4
8-K
EX-4.2
1l1nkj xwr
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
8-K
3tbv27hoqpywxt
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
424B5
0y3oq4nufs7hk7
9 Nov 22
Prospectus supplement for primary offering
11:56am
8-K
EX-4.1
t280xn izp0dg6z
23 Jun 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-4.1
2wy gtvcv
19 Jul 21
Entry into a Material Definitive Agreement
8:01am
8-K
EX-4.1
k1tj35u p9v
2 Jul 21
Entry into a Material Definitive Agreement
4:05pm
8-K
3ar7j9
15 Jun 21
Completion of Acquisition or Disposition of Assets
5:11pm
8-K
EX-3.3
yj0daft2v555
15 Jun 21
Completion of Acquisition or Disposition of Assets
5:11pm
424B3
va0zf4oldfu 4pl
13 Apr 21
Prospectus supplement
4:22pm
S-4/A
lfxkz0na qyiek
9 Apr 21
Registration of securities issued in business combination transactions (amended)
5:20pm
S-4
sj1b5l72s17x25nu
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.39
kmik5bymj9makivpc
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.38
ihnp5i3 7kdp
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.34
nv7afr9so7pe74 9j
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
425
EX-10.1
vuv a0g29f0g
20 Jan 21
Business combination disclosure
8:45am